• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Pfizer Europe Emblaveo (aztreonam / avibactam) Receives Approval in Europe

    EMA

    EU Approves Pfizer`s EMBLAVEO For MDR Infections

    BUSINESSWIRE

    Hospira, Inc`s Generic Aztreonam Receives Approval In US

    FDA

    Hospira, Inc’s Generics Aztreonam Receives Approvals In US

    FDA

    The effect of generic market entry on antibiotic prescriptions in the US

    NATURE

    Allergan Receives FDA (QIDP) Designation & Fast Track Designation For ATM-AVI

    PR NEWSWIRE

    Basilea moves closer to US filing of novel antibiotic

    PMLIVE

    Enforcement Report - Week of May 16, 2018

    FDA

    Melinta Therapeutics seeks US FDA approval for Baxdela to treat ABSSSI

    PHARMABIZ

    HHS, AstraZeneca ink partnership to develop multiple drugs for multi-drug resistant bacterial infections

    PHARMABIZ

    Inspired by $220M in BARDA funding, AstraZeneca steps up antibiotics R&D

    FIERCE BIOTECH

    Allergan Announces FDA Approval of Updated Label for TEFLARO® (ceftaroline fosamil)

    PR NEWS WIRE

    Study finds essential antibiotics are often in short supply in U.S.

    FIERCE PHARMA MANUFACTURING

    Walgreens Infusion Services, Ongoing Class II recall of Aztreonam 1 gram in normal saline because of Lack of sterility assurance.

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.